The field report
438

THE CLINIC

SECTION 12

ISSUE 001

PROJECTIONproduct1-3yconfidence / low

Patient-Controlled Health Memory

Projection: Note automation and medical evidence products do not yet give individuals a portable longitudinal account of their care. A permissioned summary could travel between agents while raw records remain distributed. Reuse across institutions, with patient-controlled access and no new central data lake, is the necessary demonstration.

Why this idea is here

What the evidence establishes.

The cited captures document clinical documentation and evidence-tool adoption. They do not establish Patient-Controlled Health Memory as a deployed mechanism. The adoption test is whether patients reuse permissioned longitudinal summaries without centralizing every raw record.

Source ledger

Read the sources.

  1. S01
    Abridge Customer Deployments

    company customer evidence / published 2026-04-17 / retrieved 2026-07-09

  2. S02
    OpenEvidence doubles valuation to $12 billion

    independent reporting / published 2026-01-21 / retrieved 2026-07-09

  3. S03
    Economy | The 2026 AI Index Report

    academic index / dated 2026-04 / retrieved 2026-07-10

  4. S04
    EIOPA survey on Generative AI adoption among insurers

    regulator survey / published 2026-02-02 / retrieved 2026-07-09

Back to all 500 ideas